216 related articles for article (PubMed ID: 31831373)
1. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
2. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Menko FH; Maher ER; Schmidt LS; Middelton LA; Aittomäki K; Tomlinson I; Richard S; Linehan WM
Fam Cancer; 2014 Dec; 13(4):637-44. PubMed ID: 25012257
[TBL] [Abstract][Full Text] [Related]
3. Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (FH) as pathogenic.
Ouchene L; Wilde B; Chan-Pak-Choon F; Camacho Valenzuela J; Brimo F; Witkowski L; Christofk H; Domecq C; Fu L; Weber E; Lemieux Anglin B; Netchiporouk E; Foulkes WD
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23221. PubMed ID: 38682608
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of cancer in patients with fumarate hydratase germline mutation.
Lehtonen HJ; Kiuru M; Ylisaukko-Oja SK; Salovaara R; Herva R; Koivisto PA; Vierimaa O; Aittomäki K; Pukkala E; Launonen V; Aaltonen LA
J Med Genet; 2006 Jun; 43(6):523-6. PubMed ID: 16155190
[TBL] [Abstract][Full Text] [Related]
5. Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
[TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome.
Sánchez-Heras AB; Dámaso E; Castillejo A; Robledo M; Teulé A; Lázaro C; Sánchez-Martínez R; Zúñiga Á; López-Fernández A; Balmaña J; Robles L; Ramon Y Cajal T; Castillejo MI; Ibañez RP; Sevila CM; Sánchez-Mira A; Escandell I; Gómez L; Berbel P; Soto JL
Orphanet J Rare Dis; 2024 Jan; 19(1):26. PubMed ID: 38279137
[TBL] [Abstract][Full Text] [Related]
7. The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas.
Zhang X; Wang C; Shen D
Pathol Res Pract; 2024 Jan; 253():154916. PubMed ID: 38029712
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in Cutaneous Leiomyomas for Detection of Familial Cancer Syndromes.
Carter CS; Skala SL; Chinnaiyan AM; McHugh JB; Siddiqui J; Cao X; Dhanasekaran SM; Fullen DR; Lagstein A; Chan MP; Mehra R
Am J Surg Pathol; 2017 Jun; 41(6):801-809. PubMed ID: 28288038
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma.
Bai J; Li X; Wen Y; Lu Q; Chen R; Liu R; Shangguan T; Ye Y; Lin J; Cai W; Kang D; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3631-3646. PubMed ID: 38376408
[TBL] [Abstract][Full Text] [Related]
10. Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine Leiomyomata.
Kipnis LM; Breen KM; Koeller DR; Levine AS; Yang Z; Jun H; Tayob N; Stokes SM; Hayes CP; Ghazani AA; Hill SJ; Rana HQ
Cancer Prev Res (Phila); 2024 May; 17(5):201-208. PubMed ID: 38638033
[TBL] [Abstract][Full Text] [Related]
11. Hereditary leiomyomatosis and renal cell carcinoma.
Schmidt LS; Linehan WM
Int J Nephrol Renovasc Dis; 2014; 7():253-60. PubMed ID: 25018647
[TBL] [Abstract][Full Text] [Related]
12. Sporadic fumarate hydratase-deficient cutaneous leiomyomatosis.
Zhang SX; Banta JC; Lee CM
J Cutan Pathol; 2024 Mar; 51(3):177-180. PubMed ID: 37944595
[No Abstract] [Full Text] [Related]
13. Multiple cutaneous and uterine leiomyomatosis: Reed's syndrome.
Bhanja DB; Sil A; Sikder B; Chandra A
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417936
[TBL] [Abstract][Full Text] [Related]
14. A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study.
Wen H; Zheng L; Zhang M; Pan X; Wang D; Qian J; Zhang X; Zhou Q; Chen N
Int J Surg Pathol; 2024 Jun; 32(4):810-816. PubMed ID: 37715637
[TBL] [Abstract][Full Text] [Related]
15. Fumarate hydratase-deficient renal cell carcinoma: an oncology care institutional experience.
Kamboj M; Gupta G; Pasricha S; Mehta A; Rawal S; Singh A; Sharma A; Durga G; Bansal D; Diwan H
APMIS; 2024 May; ():. PubMed ID: 38775301
[TBL] [Abstract][Full Text] [Related]
16. A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.
Yang Y; Valera V; Sourbier C; Vocke CD; Wei M; Pike L; Huang Y; Merino MA; Bratslavsky G; Wu M; Ricketts CJ; Linehan WM
Cancer Genet; 2012; 205(7-8):377-90. PubMed ID: 22867999
[TBL] [Abstract][Full Text] [Related]
17. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
18. Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma.
Zavoshi S; Lu E; Boutros PC; Zhang L; Harari A; Hatchell KE; Nielsen SM; Esplin ED; Ouyang K; Nykamp K; Wilde B; Christofk H; Shuch B
Urology; 2023 Jun; 176():106-114. PubMed ID: 36773955
[TBL] [Abstract][Full Text] [Related]
19. Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Chen J; Hu X; Zhao J; Yin X; Zheng L; Guo J; Chen J; Wang Y; Sheng X; Dong H; Liu X; Zhang X; Liang J; Liu H; Yao J; Liu J; Shen Y; Chen Z; He Z; Wang Y; Chen N; Nie L; Zhang M; Pan X; Chen Y; Liu H; Zhang Y; Tang Y; Zhu S; Zhao J; Dai J; Wang Z; Zeng Y; Wang Z; Huang H; Liu Z; Shen P; Zeng H; Sun G
Clin Cancer Res; 2024 Jun; 30(11):2571-2581. PubMed ID: 38512114
[TBL] [Abstract][Full Text] [Related]
20. FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.
Wilde BR; Chakraborty N; Matulionis N; Hernandez S; Ueno D; Gee ME; Esplin ED; Ouyang K; Nykamp K; Shuch B; Christofk HR
Cancer Discov; 2023 Sep; 13(9):2072-2089. PubMed ID: 37255402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]